NorthView Acquisition Corp. (NVACU) Prices Upsized $165M IPO

NorthView Acquisition Corp. announced the pricing of its upsized $165 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NVACU” Monday, December 20.

The new SPAC intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion. NorthView is led by Co-Founder and CEO Jack Stover, Co-Founder and CFO Fred Knechtel, and Chairman of the Board Peter O’Rourke.

Total SPAC deal count for 2021 year-to-date is now 607. This offering is expected to close on Wednesday, December 22.

I-Bankers Securities, Inc. is acting as the sole book-running manager of the offering and Dawson James Securities, Inc. is acting as co-manager of the offering. Schiff Hardin LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.